Donation

Donate
Myeloma Minute
Sequential T-Cell Engagement for Myeloma (“STEM”) Trial: A Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy

The STEM Trial Phase II Study on Cevostamab Consolidation After BCMA CAR T-Cell Therapy 

January 8, 2024
ASH
BMS-986393 (CC-95266), a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)–Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 Study

Updates in Myeloma Treatment: BMS-986393 CAR T-Cell Therapy Shows Promise in Phase I Study for Relapsed/Refractory Patients

January 8, 2024
ASH
Impact of Dexamethasone (Dex) Dose Strength on Outcomes in Newly Diagnosed Multiple Myeloma (NDMM): A Secondary Analysis of SWOG Studies S0777 and S1211

Impact of Dexamethasone (Dex) Dose Strength on Newly Diagnosed Multiple Myeloma

January 4, 2024
ASH
Randomized Phase III Study of Pomalidomide Cyclophosphamide Dexamethasone (PCd) Versus Pomalidomide Dexamethasone (Pd) in Relapse or Refractory Myeloma: An Asian Myeloma Network (AMN) Study Presented at ASH 2023

Optimizing Myeloma Treatment: Pomalidomide-based Regimens Compared in Asian Myeloma Network (AMN) Study — a Phase III Analysis of PCd vs. Pd for Relapse or Refractory Myeloma (RRMM)

January 4, 2024
ASH
2023 ASH IMWG Conf Series banner with no button

IMWG Conference Series 2023: Making Sense of Treatment

December 14, 2023
IMWG
What is the IMF's iStopMM study?

What is the IMF's iStopMM study?

December 7, 2023
Ask Dr. Durie
How is the Black Swan Research Initiative Approaching Early Myeloma Development? 

How is the Black Swan Research Initiative Approaching Early Myeloma Development?

November 30, 2023
Ask Dr. Durie
What is high-risk smoldering multiple myeloma?

What is high-risk smoldering multiple myeloma?

November 16, 2023
Ask Dr. Durie
M-Power Community Workshop live in Detroit on November 4, 2023.

M-Power Detroit: Community Workshop 2023

November 4, 2023
Health Equity
Myeloma Made Simple: Disparities Made Simple | What Health Disparities Do Minority Patients Face?

Myeloma Made Simple: Disparities Made Simple | What Health Disparities Do Minority Patients Face?

October 26, 2023
Myeloma Made Simple
What is the IMF's Asian Myeloma Network? | Enhancing myeloma care in Asia and globally.

What is the IMF's Asian Myeloma Network? | Enhancing myeloma care in Asia and globally.

October 26, 2023
Ask Dr. Durie
Unlocking emotional freedom techniques with Rebecca Rooney

Unlocking Emotional Freedom Technique (EFT) for Myeloma Patients and Care Partners | Tap into Healing

October 23, 2023
Living Well with Myeloma

Give Where Most Needed

Learn More